http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002155538-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1203d70402f3207a082156986a3c3159 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-52 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52 |
| filingDate | 2002-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a07ce7c31eefd75407f89d3b361a202c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4caaf7034fc801af6f1592b8c719799 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6761f5a43d56552cbfd5be8ec998650c |
| publicationDate | 2002-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2002155538-A1 |
| titleOfInvention | Novel endothelial growth factor |
| abstract | The present invention provides a novel endothelial growth factor (NVR) and polynucleotides which identify and encode NVR. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding NVR and a method for producing NVR. The invention also provides for agonists, antibodies, or antagonists specifically binding NVR, and their use, in the prevention and treatment of diseases associated with expression of NVR. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding NVR for the treatment of diseases associated with the expression of NVR. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding NVR. |
| priorityDate | 1997-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1906.